Trials / Completed
CompletedNCT06580587
A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)
A Clinical Study to Evaluate the Breast Milk, Plasma and Whole Blood Pharmacokinetics of MK-8527 in Healthy Lactating Female Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to learn how MK-8527 moves through the healthy person's body over time. Researchers will measure for the amount of MK-8527 in breast milk that the baby will receive at many time points.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-8527 | Oral administration |
Timeline
- Start date
- 2025-04-15
- Primary completion
- 2026-03-27
- Completion
- 2026-03-27
- First posted
- 2024-08-30
- Last updated
- 2026-04-16
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06580587. Inclusion in this directory is not an endorsement.